2/19
11:01 am
valn
Valneva's Lyme disease vaccine offers beacon of hope amid 2025 sales dip [Yahoo! Finance]
Medium
Report
Valneva's Lyme disease vaccine offers beacon of hope amid 2025 sales dip [Yahoo! Finance]
2/19
01:00 am
valn
Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook
Low
Report
Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook
2/13
11:45 am
valn
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
Low
Report
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
2/3
02:19 am
valn
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ® [Yahoo! Finance]
Low
Report
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ® [Yahoo! Finance]
2/3
01:00 am
valn
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ®
Low
Report
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ®
1/20
07:15 pm
valn
Valneva to withdraw Chikungunya vaccine from US amid safety woes [Yahoo! Finance]
Low
Report
Valneva to withdraw Chikungunya vaccine from US amid safety woes [Yahoo! Finance]
1/19
12:00 pm
valn
Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
Low
Report
Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
1/9
01:00 am
valn
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
Low
Report
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
12/31
12:31 pm
valn
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement [Yahoo! Finance]
Low
Report
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement [Yahoo! Finance]
12/31
11:45 am
valn
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
Low
Report
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
12/10
11:45 am
valn
Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
Low
Report
Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
12/6
01:36 am
valn
Low
Report